GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 7,750.00
-340.00 (-4.20%)
At close: Jul 20, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 140.96 billion as of July 21, 2026. Its market cap has decreased by -16.65% in one year.
Market Cap
140.96B
Enterprise Value
219.10B
Revenue
179.05B
Ranking
n/a
PE Ratio
74.62
Stock Price
7,750.00
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 140.96B, a decrease of -36.48%. That is a compound annual growth rate of -6.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 139.16B | -14.20% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 162.90B |
| Cosmax Nbt | 162.79B |
| CellBion | 158.09B |
| Vivozon Pharmaceutical | 143.49B |
| Kyung Dong Pharmaceutical | 132.96B |
| Ahn-Gook Pharmaceutical | 129.34B |
| PHARMARESEARCH BIO | 127.93B |
| High Tech Pharm | 111.75B |